RxDoctor Payments Data

Lindsay Eun, MD

Obstetrics & Gynecology · Arvada, CONPI 1053467662

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $966 and has fallen 62.3% since, to $364 in 2025.

$3,667in general payments, 2019–2025

Across 169 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$702
  • Astellas Pharma US Inc$361
  • Hologic Sales And Service, LLC$327
  • Bayer$179
  • Exeltis, USA Inc.$174
  • Mayne Pharma Commercial LLC$173
  • plus $2K from 34 others
$35,931in research payments, 2019–2025

Across 29 payments — averaging $1239.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$36K

What the payments were for

  • Food & beverage$3,52996%
  • Education$1384%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,667 in reported general payments places this provider in the 85th percentile of 705 obstetrics & gynecology providers in Colorado.

See all obstetrics & gynecology providers in Colorado

Medicare billing

Part B allowed, 2024
$18,962
Medicare patients
108
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol92$6,971
Estradiol (Twice Weekly)Estradiol30$3,316
DottiEstradiol12$2,999
ProgesteroneProgesterone, Micronized29$1,081
Clindamycin Phosphate20$1,042
ValacyclovirValacyclovir Hcl12$672
Clobetasol Propionate37$576
Metronidazole26$438
Medroxyprogesterone Acetate17$153

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Arvada

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →